Johnson & Johnson to Buy Neurological Drug Maker Intra-Cellular for $14.6 Billion
On Monday, Johnson & Johnson (NYSE: JNJ) said it would buy neurological drug maker Intra-Cellular Therapies (NASDAQ: ITCI) for $14.6 […]
Johnson & Johnson to Buy Neurological Drug Maker Intra-Cellular for $14.6 Billion Read More »
